Limfa Therapy ®: Next Generation Stem Cell Treatment for Bone and Tissue Healing
At The Churchill Center, we offer Limfa Therapy, a cutting-edge treatment that harnesses the power of next-generation stem cells to promote bone and tissue healing. Limfa Therapy is particularly effective in addressing conditions like osteoarthritis, where the regeneration of damaged tissues is crucial.
Limfa Therapy utilizes advanced techniques to isolate and concentrate stem cells from your own body. These stem cells are then reintroduced into the affected area, stimulating the natural healing process. The result is accelerated tissue repair, reduced inflammation, and improved joint function.
Our skilled and experienced medical team at The Churchill Center specializes in Limfa Therapy, providing personalized and comprehensive care. We understand the unique challenges of osteoarthritis and other conditions related to bone and tissue healing, and we are dedicated to helping our patients regain their mobility and quality of life.
Experience the benefits of Limfa Therapy and discover a non-invasive and natural solution for bone and tissue healing. Contact The Churchill Center today to learn more and schedule a consultation with our expert team. Our goal is to provide you with the highest level of care and support on your journey to improved health and well-being.
Limfa uses finely tuned and patented magnetotransduction sequences to effect permeability and ion transfer of the cell membrane. This enhanced, tissue-targeted movement of ions supports chemical cascades needed for optimized cell function and healing.
- Osteoporosis: ( this is the signature treatment of Limfa it will revolutionize many industries! )
- Stem cell therapy
- Fibromyalgia
- Osteoarthritis
- Carpal Tunnel Syndrome
- Bone and tissue healing
And we have research on other diseases as well. For each of the disease states, we have a successful research.
Osteoporosis so far these are the outcomes:
Limfa to bisphosphonates (Denosumab) comparison:
Bisphosphonates Limfa (+vit D) | BMD | TBS | T-Score |
LIMFA TREATMENT RESULTS:
- 167% increase in type 2 collagen formation. 1800% increase in RUNX2 transcription factor.
- (Scientifically significant is only a 5% change)
FACTS:
Fibromyalgia has a worldwide presence affecting nearly 1 in 20 people globally. In the United States nearly 2–10% of the general population of all ages are affected by this condition – over 5M people. Women have a far higher rate of Fibromyalgia than men.
LIMFA TREATMENT RESULTS:
- 67% reduction in pain & functionality score related to the Fibromyalgia Impact Questionnaire.
- 63% reduction in pain & functionality score
NOTE: There is currently NO treatment for Fibromyalgia other than pharmaceutical drugs. Limfa’s research and efficacy is positioned to dramatically impact the healthcare field for this condition.
FACTS:
Osteoarthritis affects over 32.5 million US adults. 14 million people have knee osteoarthritis problems. Worldwide, an estimated 500 million people have osteoarthritis. Cases of osteoarthritis increased globally by 113% in 3 decades.
LIMFA TREATMENT RESULTS:
- 54% increase in mobility
- 67% reduction in pain (VAS)
- 85% improved patient satisfaction
NOTE: There is currently NO treatment for Osteoarthritis other than pharmaceutical drugs. Stem cell therapy, and PRP (which work well for some but not for others).
FACTS:
CTS affects approximately 3 to 6 percent of adults in the general population. According to the Rheumatology Research Foundation, CTS impacts 4 to 10 million Americans.
LIMFA TREATMENT RESULTS:
- 40% decrease in pain (VAS)
- 1 month of treatment.
- 95% decrease in pain (VAS)
- 3 months of treatment.
NOTE: There is currently NO treatment for CTS other than pharmaceutical drugs, NSAIDs, injections, immobilization, or surgery. Limfa’s research and efficacy is positioned to dramatically impact the healthcare field for this condition.
Approximately 6.3 million fractures occur each year in the U.S. Globally, 310 million major surgeries are performed each year, with around 40 to 50 million in USA and 20 million in Europe.
LIMFA TREATMENT RESULTS:
90% increase in bone consolidation after 1 month.
Bone healing delay occurs in 10% of fracture cases (as well as pseudoarthrosis during spinal fusion).
Limfa found resolution with only 1 month of therapy at a 90% success rate.
Bones were totally healed after 3 months.
Treatment was 3 treatments per week for 4 to 5 weeks.
Future studies are planned for the following industries and health conditions:
- Sleep
- Anti-Aging / Longevity
- Bed Sores
- Immune Function
- Plantar fasciitis
- Cancer Prevention &
- Cancer Treatment
- Erectile Dysfunction
- Prostate
- Sports Medicine
- Post-workout recovery
- Diabetic neuropathy
- Vaginal Rejuvenation
- Neck & back pain
- Headaches
- Concussions
Each treatment will retail for 150.00 USD.
Limfa is made in Italy.
